Pathophysiology of the polycystic ovary syndrome;Physiopathologie du syndrome des ovaires polymicrokystiques

Annales d'Endocrinologie

Volumn 60, Issue 2, 1999, Pages 123-130

  Dewailly, D ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; FOLLISTATIN; INHIBIN;

ANOVULATION; ARTICLE; ENZYME ACTIVITY; FEMALE; GRANULOSA CELL; HUMAN; HYPERANDROGENISM; HYPERINSULINISM; OVARY POLYCYSTIC DISEASE; THECA CELL;

FEMALE; FOLLICLE STIMULATING HORMONE; GRANULOSA CELLS; HUMANS; HYPERANDROGENISM; HYPERINSULINISM; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME; RECEPTORS, FSH; THECA CELLS;

EID: 0032774922     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. DEWAILLY D. Definition and Significance of Polycystic Ovaries. In Hyperandrogenic States and Hirsutism. RL Rosenfield, Ed. Balliere's Clinical Obstetrics and Gynaecology, 1997; vol. 11(2), pp. 349-68.
2. TAYLOR AE, HALL JE Disordered gonadotropin secretion in polycystic ovary syndrome. In The Ovary: Regulation, Dysfunction and Treatment. M. Filicori and C. Flamigni, eds. Elsevier Science B.V., 1996; pp. 187-194.
3. FILICORI M, TABARELLI C, COGNIGNI GE, POCOGNOLI P, FALBO A, SPETOLLI D, ARNONE R, CIAMPAGLIA W. Multifollicular ovary in adult infertile women: a new distinct clinical entity? In The Ovary: Regulation, Dysfunction and Treatment. M. Filicori and C. Flamigni, eds. Elsevier Science B.V., 1996; pp. 253-57.
4. th annual meeting of the Endocrine Society, New Orleans, June 24-27th, 1998; Abstract P1-365, p. 196.
5. ROSENFIELD RL. Ovarian secretory abnormalities in PCOS. In Androgen Excess Disorders in Women. Azziz R., Nestler JE, and Dewailly D, eds. Lippincott-Raven Publishers, Philadelphia, 1997; pp. 303-13.
6. GELLER DH, AUCHUS RJ, MILLER WL. The role of P450c17 in adrogen biosynthesis. In Androgen Excess Disorders in Women. Azziz R, Nestler JE and Dewailly D, eds. Lippincott-Raven Publishers, Philadelphia, 1997; pp. 315-25.
7. GILLING-SMITH C, STORY H, ROGERS V, FRANKS S. Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin Endocrinol (Oxf) 1997; 47: 93-9.
8. FRANKS S, GHARANI N, WATERWORTH D, BATTY S, WHITE D, WILLIAMSON R, MCCARTHY M. The genetic basis of polycystic ovary syndrome. Hum Reprod 1997; 12: 2641-8.
9. CARMINA E. Prevalence of adrenal androgen excess in PCOS. In Androgen Excess Disorders in Women. Azziz R, Nestler JE and Dewailly D, eds. Lippincott-Raven Publishers, Philadelphia, 1997; pp. 385-93.
10. GHARANI N, WATERWORTH DM, BATTY S, WHITE D, GILLING-SMITH C, CONWAY GS, MCCARTHY M, FRANKS S, WILLIAMSON R. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet 1997; 6: 397-402.
11. GIUDICE LC. Role of insulin-like growth factors (IGF) and IGF Binding Proteins in PCOS. In Androgen Excess Disorders in Women. Azziz R, Nestler JE and Dewailly D, eds. Lippincott-Raven Publishers, Philadelphia, 1997; pp. 507-19.
12. MASON HD, CWYFAN-HUGHES S, HOLLY JM, FRANKS S. Potent inhibition of human ovarian steroidogenesis by insulin-like growth factor binding protein-4 (IGFBP-4). Clin Endocrinol Metab 1998; 83: 284-7.
13. UDOFF LC, ADASHI EY. Intraovarian regulation of ovarian androgen secretion in PCOS. In Androgen Excess Disorders in Women. Azziz R, Nestler JE and Dewailly D, eds. Lippincott-Raven Publishers, Philadelphia, 1997; pp. 295-301.
14. YAMOTO M, MINAMI S, NAKANO R. Immunohistochemical localization of inhibin subunits in polycystic ovary. J Clin Endocrinol Metab 1993; 77: 859-62.
15. ROBERTS VJ, BARTH S, EL-ROEIY A, YEN SS. Expression of inhibin/activin system mRNAs and proteins in ovarian follicles from women with PCOS. J Clin Endocrinol Metab. 1994; 79: 1434-39.
16. PIGNY P, DESAILLOUD R, CORTET-RUDELLI C. et al. Serum a-inhibin levels in PCOS: relationship to the serum androstenedione level. J Clin Endocrinol Metab 1997; 82: 1939-43.
17. LOCKWOOD GM, MUTTIKRISHNA S, GROOME NP, MATTHEWS DR, LEDGER WL. Mid-follicular phase pulses of inhibin B are absent in Polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergency of the dominant follicle. J Clin Endocrinol Metab. 1998; 83: 1730-35.
18. ANDERSON RA, GROOME NP, BAIRD DT. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce monoovulation. Clin Endocrinol. 1998; 48: 577-84.
19. FRANKS S, MASON H, WHITE D, WILLIS D. Mechanisms of anovulation in polycystic ovary syndrome. In The Ovary: Regulation, Dysfunction and Treatment. Filicori M and Flaminni C, eds. Elsevier Science B.V., 1996; pp. 183-86.
20. HUGHESDON PE Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called «hyperthecosis». Obstet Gynecol Surv 1982; 37: 59-77.
21. MASON HD, WILLIS DS, BEARD RW, WINSTON RML, MARGARA R, FRANKS S. Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid. J Clin Endocrinol Metab 1994; 79: 1355-60.
22. ERICKSON GF, MAGOFFIN DA, GARZO VG, CHEUNG AP, CHANG RJ. Granulosa cells of polycystic ovaries: are they normal or abnormal? Hum Reprod 1992; 7: 293-9.
23. WILLIS DS, WATSON H, MASON HD, GALEA R, BRINCAT M, FRANKS S. Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. J Clin Endocrinol Metab 1998; 83: 3984-91.
24. VENDOLA KA, ZHOU J, ADESANYA OO, WEIL SJ, BONDY CA. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 1998; 101: 2622-29.
25. ABBOTT DH, DUMESIC DA, EISNER JR, KEMNITZ JW, GOY RW. The prenatally androgenized female Rhesus monkey as a model for PCOS. In Androgen Excess Disorders in Women. Azziz R, Nestler JE and Dewailly D, eds. Lippincott-Raven Publishers, Philadelphia, 1997; pp. 369-84.
26. DONESKY BW, ADASHI EY. Surgically induced ovulation in the Polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy. Fertil Steril, 1995; 63 (3): 439-63.
27. DE LEO V, LANZETTA D, D'ANTONA D, LA MARCA A, MORGANTE G. Hormonal effects of flutamide in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998; 83: 99-102.
28. DUNAIF A. Molecular mechanisms of insulin resistance in PCOS. In Androgen Excess Disorders in Women. Azziz R, Nestler JE and Dewailly D, eds. Lippincott-Raven Publishers, Philadelphia, 1997; pp. 485-96.
29. HOLTE J. Insulin secretion and sensitivity in polycystic ovary syndrome. Role of body fat distribution. In The Ovary: Regulation, Dysfunction and Treatment. Filicori M and Flamigni C, eds. Elsevier Science B.V., 1996; pp. 237-50.
30. NESTLER JE. Insulin and ovarian androgen excess. In Androgen Excess Disorders in Women. Azziz R, Nestler JE and Dewailly D, eds. Lippincott-Raven Publishers, Philadelphia, 1997; pp. 473-483.
31. DUNAIF A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997, 18: 774-800.